UK Biobank is a very large and detailed prospective study with over 500,000 participants
aged 40–69 years when recruited in 2006–2010.
• The study has collected and continues to collect extensive phenotypic and genotypic detail
about its participants, including data from questionnaires, physical measures, sample
assays, accelerometry, multimodal imaging, genome-wide genotyping and longitudinal
follow-up for a wide range of health-related outcomes.
• Wide consultation; input from scientific, management, legal, and ethical partners; and
industrial-scale, centralised processes have been essential to the development of
this resource.
• UK Biobank is available for open access, without the need for collaboration, to any bona
fide researcher who wishes to use it to conduct health-related research for the benefit of
the public.